Ultragenyx Pharmaceutical Investor Relations Material
Latest events
Q1 2025
Ultragenyx Pharmaceutical
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Ultragenyx Pharmaceutical Inc
Access all reports
Ultragenyx Pharmaceutical Inc. is a biopharmaceutical company dedicated to developing and commercializing therapies for rare and ultra-rare genetic diseases. The company's focus includes treatments for metabolic disorders, bone diseases, and other conditions with significant unmet medical needs. Ultragenyx leverages innovative research and targeted approaches to address complex diseases that often lack effective therapies.The company is headquartered in Novato, California, and its shares are listed on the NASDAQ.
Key slides for Ultragenyx Pharmaceutical Inc
Q1 2025
Ultragenyx Pharmaceutical Inc
Q2 2024
Ultragenyx Pharmaceutical Inc
Latest articles
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
)
Costco Wholesale: The Model of Scalable Simplicity
Costco's rise from warehouse club to retail giant is built on low prices, scale efficiency, and a model designed for lasting customer value.
26 May 2025
Ticker symbol
RARE
Country
🇺🇸 United States